Calcium Disodium EDTA vs Neotame: which is worse?

What is Calcium Disodium EDTA?

Calcium disodium EDTA (ethylenediaminetetraacetate) is a chelating agent used as a food preservative. It binds metal ions (particularly iron and copper) that would otherwise catalyze oxidative and color-degradation reactions in foods. It prevents color loss, flavor changes, and bacterial growth in certain foods.

What is Neotame?

Neotame is a synthetic dipeptide sweetener — a derivative of aspartame with a 3,3-dimethylbutyl group added to block aspartame's metabolism, preventing the release of phenylalanine. This means it is safe for people with phenylketonuria (PKU), unlike aspartame. It is approximately 7,000-13,000 times sweeter than sucrose.

Documented risks

Calcium Disodium EDTA: EDTA chelates essential minerals including zinc, iron, calcium, and magnesium in the gut, potentially reducing absorption of these nutrients with regular consumption. Animal studies at high doses show reproductive toxicity and zinc deficiency effects. EFSA's safety assessment noted that EDTA could reduce zinc bioavailability at consumption levels that could be reached by high consumers of EDTA-containing foods. The ADI is 1.9 mg/kg body weight. EDTA's poor biodegradability also makes it an environmental concern — it accumulates in water supplies and can mobilize heavy metals in sediments.

Neotame: Neotame is one of the newer synthetic sweeteners with a shorter safety track record. A 2023 study published in Frontiers in Nutrition found that neotame damaged intestinal epithelial cells in vitro and disrupted the gut microbiome in mice — including reducing beneficial bacteria and increasing bacterial invasion of intestinal cells. The study observed effects at concentrations that could be achievable through high consumption of neotame-containing products. The FDA has set an ADI of 0.3 mg/kg/day, one of the lower sweetener ADIs, reflecting a conservative safety margin. Limited long-term human safety data exist compared to aspartame, acesulfame K, or saccharin, which have been used for decades. EFSA's 2010 opinion found no safety concern at permitted levels. The Frontiers in Nutrition 2023 gut study represents new concerning findings that warrant further investigation.